Alkynyl derivatives as modulators of metabotropic glutamate receptors

Details for Australian Patent Application No. 2005254808 (hide)

Owner Addex Pharma SA

Inventors Bonnet, Beatrice; Bolea, Christelle; Rocher, Jean-Philippe; Bessis, AnneSophie; Thollon, Yves; Poli, SoniaMaria; Poirier, Nicholas; Epping-Jordan, Mark

Agent Spruson & Ferguson

Pub. Number AU-B-2005254808

PCT Pub. Number WO2005/123703

Priority 0413605.7 17.06.04 GB

Filing date 17 June 2005

Wipo publication date 29 December 2005

Acceptance publication date 19 April 2012

International Classifications

C07D 213/56 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/4035 (2006.01)

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/47 (2006.01) - Quinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 215/06 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 239/26 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 263/56 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 277/22 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2005/123703 Priority application(s): WO2005/123703

19 July 2007 Change of Name(s) of Applicant(s), Section 104

  Addex Pharmaceuticals SA The name of the applicant has been changed to Addex Pharma SA

19 April 2012 Application Accepted

  Published as AU-B-2005254808

16 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005254821-Reinforcement binder and wire reel

2005254807-Thymidine kinase